Inflammatix

Biotechnology

United States, California

$25M to $50M

51-200

Provivi

Biotechnology

United States, California

$25M to $50M

51-200

Deepcell

Biotechnology

United States, California

$25M to $50M

51-200

Pacific Edge

Biotechnology

United States, Pennsylvania

$25M to $50M

51-200

Kallyope

Biotechnology

United States, New York

$25M to $50M

51-200

Omniome

Biotechnology

United States, California

$25M to $50M

51-200

Prelude Therapeutics

Biotechnology

United States, Delaware

$25M to $50M

51-200

Cytozyme

Biotechnology

United States, Utah

$25M to $50M

51-200

Premier Select Sires

Biotechnology

United States, Pennsylvania

$25M to $50M

51-200

Allena Pharmaceuticals

Biotechnology

United States, Massachusetts

$25M to $50M

51-200

Veloxis Pharmaceuticals

Biotechnology

United States, North Carolina

$25M to $50M

51-200

BIOPAC Systems

Biotechnology

United States, California

$25M to $50M

51-200

AlloVir

Biotechnology

United States, Massachusetts

$25M to $50M

51-200

Viking Pure Solutions

Biotechnology

United States, Florida

$25M to $50M

51-200

Cresilon

Biotechnology

United States, New York

$25M to $50M

51-200

Renalytix

Biotechnology

United States, New York

$25M to $50M

51-200

Jeneil Biotech

Biotechnology

United States, Wisconsin

$25M to $50M

51-200

StemCyte

Biotechnology

United States, California

$25M to $50M

51-200

RayBiotech

Biotechnology

United States, Georgia

$25M to $50M

51-200

Dyne Therapeutics

Biotechnology

United States, Massachusetts

$25M to $50M

51-200